TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells☆
To access this article, please choose from the options below
☆ Grant support: Supported by grants from “Associazione Italiana Ricerca sul Cancro” (A.I.R.C.), “Ministero della Salute”, “CNR-MIUR”, “La Ligue Nationale contre le Cancer” and “Canceropole program EPIMED”. A. Rizzo is recipient of a fellowship from Italian Foundation for Cancer Research (F.I.R.C.).
PII: S0959-8049(06)00333-9
doi:10.1016/j.ejca.2006.03.010
© 2006 Elsevier Ltd. All rights reserved.
